Moneycontrol PRO

you are here: HomeNewsBusinessEarningsR&D spends weighed heavily on Q4 margins: Ajanta Pharma

SHOW NAMES

Trending Topics

business

R&D spends weighed heavily on Q4 margins: Ajanta Pharma

The pharma company had posted strong fourth quarter profits but margins had contracted. The R&D spend for the quarter stood at 9 percent, says Yogesh M Agrawal, Managing Director of the company.

first published: Apr 29, 2016 03:35 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347